Author/Creator: Tapper, E. B. - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Tapper, E. B.

1. Aspirin use is associated with lower indices of liver fibrosis among adults in the United States. Issue 6 (7th January 2016)

Authors:: Jiang, Z. Gordon; Feldbrügge, L.; Tapper, E. B.; Popov, Y.; Ghaziani, T.; Afdhal, N.; Robson, S. C.; Mukamal, K. J.
Journal:: Alimentary pharmacology & therapeutics
Issue:: Volume 43:Issue 6(2016)
Page Start:: 734
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Direct costs of first‐generation protease inhibitors for the treatment of genotype 1 chronic hepatitis C viral infection. Issue 12 (25th May 2015)

Authors:: Sethi, N.; Tapper, E. B.; Vong, A.; Sethi, S.; Rourke, M.; Afdhal, N. H.
Journal:: Journal of viral hepatitis
Issue:: Volume 22:Issue 12(2015)
Page Start:: 974
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Editorial: the impact of steatosis on liver stiffness quantification is minimal. Issue 10 (19th April 2018)

Authors:: Hassan, A.; Tapper, E. B.
Journal:: Alimentary pharmacology & therapeutics
Issue:: Volume 47:Issue 10(2018)
Page Start:: 1416
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. Effectiveness of 8‐ or 12‐weeks of ledipasvir and sofosbuvir in real‐world treatment‐naïve, genotype 1 hepatitis C infected patients. Issue 5 (10th July 2017)

Authors:: Curry, M. P.; Tapper, E. B.; Bacon, B.; Dieterich, D.; Flamm, S. L.; Guest, L.; Kowdley, K. V.; Lee, Y.; Milligan, S.; Tsai, N.; Younossi, Z.; Afdhal, N. H.
Journal:: Alimentary pharmacology & therapeutics
Issue:: Volume 46:Issue 5(2017)
Page Start:: 540
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. Is 3 the new 1: perspectives on virology, natural history and treatment for hepatitis C genotype 3. Issue 10 (8th September 2013)

Authors:: Tapper, E. B.; Afdhal, N. H.
Journal:: Journal of viral hepatitis
Issue:: Volume 20:Issue 10(2013)
Page Start:: 669
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. Letter: seasonality in eosinophilic oesophagitis and food bolus obstruction – what about recurrent episodes? – Authors' reply. Issue 7 (2nd September 2015)

Authors:: Sengupta, N.; Tapper, E. B.; Lembo, A. J.
Journal:: Alimentary pharmacology & therapeutics
Issue:: Volume 42:Issue 7(2015)
Page Start:: 937
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

7. Letter: seasonality in eosinophilic oesophagitis and food bolus obstruction – what about recurrent episodes? – Authors' reply. Issue 7 (October 2015)

Authors:: Sengupta, N.; Tapper, E. B.; Lembo, A. J.
Journal:: Alimentary pharmacology & therapeutics
Issue:: Volume 42:Issue 7(2015)
Page Start:: 937
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

8. Letter: would aspirin alleviate fibrosis in alcoholic liver disease? Authors' reply. Issue 2 (July 2016)

Authors:: Jiang, Z. G.; Feldbrügge, L.; Tapper, E. B.; Popov, Y.; Ghaziani, T.; Afdhal, N.; Robson, S. C.; Mukamal, K. J.
Journal:: Alimentary pharmacology & therapeutics
Issue:: Volume 44:Issue 2(2016)
Page Start:: 209
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

9. Low‐fasting triglyceride levels are associated with non‐invasive markers of advanced liver fibrosis among adults in the United States. Issue 1 (27th April 2015)

Authors:: Jiang, Z. G.; Tsugawa, Y.; Tapper, E. B.; Lai, M.; Afdhal, N.; Robson, S. C.; Mukamal, K. J.
Journal:: Alimentary pharmacology & therapeutics
Issue:: Volume 42:Issue 1(2015)
Page Start:: 106
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

10. Real‐world effectiveness for 12 weeks of ledipasvir–sofosbuvir for genotype 1 hepatitis C: the Trio Health study. Issue 1 (11th October 2016)

Authors:: Tapper, E. B.; Bacon, B. R.; Curry, M. P.; Dieterich, D. T.; Flamm, S. L.; Guest, L. E.; Kowdley, K. V.; Lee, Y.; Tsai, N. C.; Younossi, Z. M.; Afdhal, N. H.
Journal:: Journal of viral hepatitis
Issue:: Volume 24:Issue 1(2017)
Page Start:: 22
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗